FENOFIBRATE 145 MG TABLET
For 30 tablets
Pharmacies pay
$3.59 filed
30 × $0.11959 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$9.13 estimated
$3.59 + $0.54 (15%) + $5.00 fee per fill = $9.13
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
FENOFIBRATE 145 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as fenofibrate.
FDA gives its dosage form as “tablet, film coated”, “tablet” and “tablet, coated” and its route as oral.
FDA lists 11 labelers (the companies named on the label) for its NDCs, among them Mylan Pharmaceuticals Inc., Major Pharmaceuticals and Camber Pharmaceuticals, Inc.
FDA’s Established Pharmacologic Class for it is Peroxisome Proliferator Receptor alpha Agonist.
The NADAC file of 2026-10-14 prices it under 19 NDCs (National Drug Codes); the FDA directory lists 17 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $3.59 for 30 tablets (30 × $0.11959 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 11 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Major Pharmaceuticals | 3 | $0.11959 per EA filed |
| Alembic Pharmaceuticals Inc. | 2 | $0.11959 per EA filed |
| American Health Packaging | 2 | $0.11959 per EA filed |
| Lupin Pharmaceuticals, Inc. | 2 | $0.11959 per EA filed |
| Mylan Pharmaceuticals Inc. | 2 | $0.11959 per EA filed |
| Aurobindo Pharma Limited | 1 | $0.11959 per EA filed |
| Camber Pharmaceuticals, Inc. | 1 | $0.11959 per EA filed |
| Cipla USA Inc. | 1 | $0.11959 per EA filed |
| Mylan Institutional Inc. | 1 | $0.11959 per EA filed |
| QUALLENT PHARMACEUTICALS HEALTH LLC | 1 | $0.11959 per EA filed |
| Solco Healthcare US, LLC | 1 | $0.11959 per EA filed |
| Not listed as a package in the FDA directory | 2 | $0.11959 per EA filed |
All 19 NDCs, with labeler and price
- 00378-3066-05 · Mylan Pharmaceuticals Inc. · $0.11959 per EA · eff. 2026-09-23 filed
- 00378-3066-77 · Mylan Pharmaceuticals Inc. · $0.11959 per EA · eff. 2026-09-23 filed
- 00904-7161-61 · Major Pharmaceuticals · $0.11959 per EA · eff. 2026-09-23 filed
- 00904-7480-04 · Major Pharmaceuticals · $0.11959 per EA · eff. 2026-09-23 filed
- 00904-7480-61 · Major Pharmaceuticals · $0.11959 per EA · eff. 2026-09-23 filed
- 31722-0596-90 · Camber Pharmaceuticals, Inc. · $0.11959 per EA · eff. 2026-09-23 filed
- 43547-0431-09 · Solco Healthcare US, LLC · $0.11959 per EA · eff. 2026-09-23 filed
- 51079-0608-01 · not listed as a package in the FDA directory · $0.11959 per EA · eff. 2026-09-23 filed
- 51079-0608-20 · Mylan Institutional Inc. · $0.11959 per EA · eff. 2026-09-23 filed
- 60687-0629-01 · American Health Packaging · $0.11959 per EA · eff. 2026-09-23 filed
- 60687-0629-11 · not listed as a package in the FDA directory · $0.11959 per EA · eff. 2026-09-23 filed
- 60687-0629-21 · American Health Packaging · $0.11959 per EA · eff. 2026-09-23 filed
- 62332-0361-71 · Alembic Pharmaceuticals Inc. · $0.11959 per EA · eff. 2026-09-23 filed
- 62332-0361-90 · Alembic Pharmaceuticals Inc. · $0.11959 per EA · eff. 2026-09-23 filed
- 65862-0769-90 · Aurobindo Pharma Limited · $0.11959 per EA · eff. 2026-09-23 filed
- 68180-0389-02 · Lupin Pharmaceuticals, Inc. · $0.11959 per EA · eff. 2026-09-23 filed
- 68180-0389-09 · Lupin Pharmaceuticals, Inc. · $0.11959 per EA · eff. 2026-09-23 filed
- 69097-0458-05 · Cipla USA Inc. · $0.11959 per EA · eff. 2026-09-23 filed
- 82009-0060-90 · QUALLENT PHARMACEUTICALS HEALTH LLC · $0.11959 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
12 other products in the NADAC file share the FDA nonproprietary name fenofibrate with FENOFIBRATE 145 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| FENOFIBRATE 40 MG TABLET | $5.53539 per EA filed | We don’t know yet |
| FENOFIBRATE 43 MG CAPSULE | $0.38364 per EA filed | We don’t know yet |
| FENOFIBRATE 48 MG TABLET | $0.07936 per EA filed | We don’t know yet |
| FENOFIBRATE 50 MG CAPSULE | $2.55969 per EA filed | We don’t know yet |
| FENOFIBRATE 54 MG TABLET | $0.07335 per EA filed | We don’t know yet |
| FENOFIBRATE 67 MG CAPSULE | $0.09197 per EA filed | We don’t know yet |
| FENOFIBRATE 120 MG TABLET | $16.75499 per EA filed | We don’t know yet |
| FENOFIBRATE 130 MG CAPSULE | $0.70221 per EA filed | We don’t know yet |
| FENOFIBRATE 134 MG CAPSULE | $0.11925 per EA filed | We don’t know yet |
| FENOFIBRATE 145 MG TABLET this page | $0.11959 per EA filed | We don’t know yet |
| FENOFIBRATE 150 MG CAPSULE | $5.30292 per EA filed | We don’t know yet |
| FENOFIBRATE 160 MG TABLET | $0.1033 per EA filed | We don’t know yet |
| FENOFIBRATE 200 MG CAPSULE | $0.16437 per EA filed | We don’t know yet |
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Compared with its class
The middle of its 19 NDCs’ NADAC prices is $0.11959 per EA filed.
Of the 23 other products in FDA’s Peroxisome Proliferator Receptor alpha Agonist class priced per EA, 14 have a higher middle NADAC price and 9 a lower one. The one in the middle is PIOGLITAZONE-METFORMIN 15-850, at $0.23908 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Related pages
Its pharmacologic class
Related in the same class
- PIOGLITAZONE HCL 15 MG TABLET
- GEMFIBROZIL 600 MG TABLET
- PIOGLITAZONE-METFORMIN 15-500
- PIOGLITAZONE-GLIMEPIRIDE 30-2
- ALOGLIPTIN-PIOGLIT 25-15 MG TB